Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kira Bang Bové"'
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0263481 (2022)
PurposeResults from large scale cardiovascular outcome trials in patients with type 2 diabetes mellitus (DM2) have found that sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce cardiovascular death and hospitalization for heart failure, but th
Externí odkaz:
https://doaj.org/article/463bc58135984e11bd652ceb2d3345e8
Autor:
Malin Nilsson, Kira Bang Bové, Elena Suhrs, Thomas Hermann, Sten Madsbad, Jens Juul Holst, Eva Prescott, Mette Zander
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 22, Iss , Pp 139-144 (2019)
Objective: Glucagon-like-peptide-1 (GLP-1) receptor analogues have been shown to reduce cardiovascular events in patients with type 2 diabetes. However, the mechanism behind is still unknown. The aim of the study was to investigate the effect of inta
Externí odkaz:
https://doaj.org/article/93c20410077c44d48af862cf53ec54a8
Autor:
Marie Mide Michelsen, Adam Pena, Eva Prescott, Kira Bang Bové, Daria Frestad Bechsgaard, Hannah Elena Suhrs, Jens D. Hove, Ida Gustafsson, Naja Dam Mygind
Publikováno v:
Evidence Based Mental Health. 24:49-55
BackgroundMore than half of women with symptoms suggestive of myocardial ischaemia have no obstructive coronary artery disease (CAD), yet they face a higher risk of cardiovascular mortality and morbidity. Both vital exhaustion (VE) and depression hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32801eec9dae7a123e6c03ea27d837bf
https://doi.org/10.1136/ebmental-2020-300175
https://doi.org/10.1136/ebmental-2020-300175
Autor:
Jens D. Hove, Persia Shahriari, Eva Prescott, Hannah Elena Suhrs, Daria Frestad Bechsgaard, Ida Gustafsson, Kira Bang Bové
Publikováno v:
International Journal of Cardiology. 293:1-9
Background Both coronary microvascular dysfunction (CMD) and reduced exercise capacity are associated with adverse cardiovascular prognosis. The association between CMD and cardiopulmonary exercise testing (CPET) derived exercise capacity in symptoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53cde20e1a062cb47c85d1256cffb204
https://doi.org/10.1016/j.ijcard.2019.07.048
https://doi.org/10.1016/j.ijcard.2019.07.048
Autor:
Steen Madsbad, Kira Bang Bové, Hannah Elena Suhrs, Kristoffer Flintholm Raft, Jens J. Holst, Mette Zander, Eva Prescott
Publikováno v:
International Journal of Cardiology. 283:28-34
Background Coronary microvascular dysfunction (CMD) is associated with adverse cardiovascular outcomes and CMD is a hallmark of type 2 diabetes. Liraglutide improves cardiovascular prognosis through partly unknown mechanisms. We hypothesized that tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::658bc4577862d6f399a987a3d56ee5d5
https://doi.org/10.1016/j.ijcard.2018.12.005
https://doi.org/10.1016/j.ijcard.2018.12.005
Autor:
Marie Mide Michelsen, Ahmed Aziz, Jakob Schroder, Naja Dam Mygind, Eva Prescott, Jens Kastrup, Kira Bang Bové, Ida Gustafsson, Daria Frestad Bechsgaard, Hannah Elena Suhrs
Publikováno v:
Schroder, J, Michelsen, M M, Mygind, N D, Suhrs, H E, Bove, K B, Bechsgaard, D F, Aziz, A, Gustafsson, I, Kastrup, J & Prescott, E 2021, ' Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease : Results from the iPOWER study ', European Heart Journal, vol. 42, no. 3, pp. 228-239 . https://doi.org/10.1093/eurheartj/ehaa944
Aims Many patients with angina, especially women, do not have obstructive coronary artery disease (CAD) yet have impaired prognosis. We investigated whether routine assessment of coronary microvascular dysfunction (CMD) is feasible and predicts adver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a497cd507700878fbc740a478247a3c8
https://portal.findresearcher.sdu.dk/da/publications/a6fc2590-8681-499a-85e7-38b94b68345d
https://portal.findresearcher.sdu.dk/da/publications/a6fc2590-8681-499a-85e7-38b94b68345d
Autor:
Henning B. Nielsen, Naja Dam Mygind, Eva Prescott, Adam Pena, Niels Vejlstrup, Kira Bang Bové, Signe Holm Nielsen, Marie Mide Michelsen, Elena Suhrs, Jens Kastrup, Daria Frestad Bechsgaard, Morten A. Karsdal, Federica Genovese
Publikováno v:
Journal of cardiovascular translational research. 14(5)
Angina and no obstructive coronary artery disease (CAD) have an unfavorable prognosis, possibly due to diffuse myocardial fibrosis (DMF). In DMF the proteoglycans biglycan and versican are actively remodeled by matrix metalloproteinase. We investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d42c573a2594ad0c3f7d54c67767dbc
https://pubmed.ncbi.nlm.nih.gov/33649986
https://pubmed.ncbi.nlm.nih.gov/33649986
Autor:
Jens Kastrup, Kira Bang Bové, M Mide Michelsen, Adam Pena, Morten A. Karsdal, S Holm Nielsen, Federica Genovese, D Bechsgaard Frestad, Eva Prescott, Niels Vejlstrup, Henning B. Nielsen, N.D. Mygind, E S Suhrs
Background Women with angina and no obstructive coronary artery disease (CAD) have an unfavourable prognosis, possibly due to coronary microvascular disease and diffuse myocardial fibrosis (DMF). In DMF myocardial extracellular matrix (ECM) proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8cf03260bd13a3edc0ea9b3785c4f04
https://doi.org/10.21203/rs.3.rs-60141/v1
https://doi.org/10.21203/rs.3.rs-60141/v1
Autor:
Kira Bang Bové, Nicolai Mikkelsen, Eva Prescott, Arne Astrup, Malin Nilsson, Hannah Elena Suhrs, Lene Rørholm Pedersen
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 11, p e0240722 (2020)
Bove, K B, Nilsson, M, Pedersen, L R, Mikkelsen, N, Suhrs, H E, Astrup, A & Prescott, E 2020, ' Comprehensive treatment of microvascular angina in overweight women-a randomized controlled pilot trial ', P L o S One, vol. 15, no. 11, e0240722 . https://doi.org/10.1371/journal.pone.0240722
PLoS ONE, Vol 15, Iss 11, p e0240722 (2020)
Bove, K B, Nilsson, M, Pedersen, L R, Mikkelsen, N, Suhrs, H E, Astrup, A & Prescott, E 2020, ' Comprehensive treatment of microvascular angina in overweight women-a randomized controlled pilot trial ', P L o S One, vol. 15, no. 11, e0240722 . https://doi.org/10.1371/journal.pone.0240722
Aims Coronary microvascular dysfunction (CMD) carries a poor cardiovascular prognosis and may explain angina in women without obstructive coronary artery disease (CAD). Currently, no evidence-based treatment for CMD exists. We investigated whether re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c7c585546c53399ff6f4a397aec36d
https://pubmed.ncbi.nlm.nih.gov/33151955
https://pubmed.ncbi.nlm.nih.gov/33151955
Autor:
Marie Mide Michelsen, Eva Prescott, Naja Dam Mygind, Anna Bay Rask, Hannah Elena Suhrs, Daria Frestad, Anna Meta Dyrvig Kristensen, Kira Bang Bové
Publikováno v:
Maturitas. 107:110-115
Reproductive risk factors such as preeclampsia and recurrent miscarriages have been associated with adverse cardiovascular (CV) events. Underlying coronary microvascular dysfunction (CMD) may be a common denominator.We investigated whether a history
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dee41cb2f7a99bc4feb8f61b97a05152
https://doi.org/10.1016/j.maturitas.2017.07.004
https://doi.org/10.1016/j.maturitas.2017.07.004